Farallon Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-14,645
| Closed | -$2.49M | – | 77 |
|
|
2015
Q3 | $2.49M | Buy |
14,645
+4,344
| +42% | +$739K | 0.03% | 71 |
|
|
2015
Q2 | $6.51M | Buy |
+10,301
| New | +$6.51M | 0.09% | 77 |
|
|
2014
Q3 | – | Sell |
-3,190
| Closed | -$4.37M | – | 93 |
|
|
2014
Q2 | $4.37M | Sell |
3,190
-4,429
| -58% | -$6.06M | 0.06% | 73 |
|
|
2014
Q1 | $10.6M | Buy |
7,619
+2,619
| +52% | +$3.64M | 0.21% | 58 |
|
|
2013
Q4 | $4.98M | Buy |
5,000
+1,595
| +47% | +$1.59M | 0.1% | 63 |
|
|
2013
Q3 | $3.55M | Buy |
3,405
+1,143
| +51% | +$1.19M | 0.07% | 68 |
|
|
2013
Q2 | $2.48M | Buy |
+2,262
| New | +$2.48M | 0.05% | 76 |
|